NCT02066727View on ClinicalTrials.gov

Lidocaine Combined Dexmedetomidine for Obturator Nerve Block

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Nerve Block
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine is administrated as an adjuvant of lidocaine at a dose of 1.0 μg/ kg.

DRUG

Normal Saline

Normal Saline is administrated as an adjuvant of lidocaine.

Trial Locations (1)

300000

Tainjin Medical University General Hospita& the Second Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Guolin Wang

OTHER

NCT02066727 - Lidocaine Combined Dexmedetomidine for Obturator Nerve Block | Biotech Hunter | Biotech Hunter